BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood.

PubWeight™: 6.04‹?› | Rank: Top 1%

🔗 View Article (PMID 11086035)

Published in J Immunol on December 01, 2000

Authors

A Dzionek1, A Fuchs, P Schmidt, S Cremer, M Zysk, S Miltenyi, D W Buck, J Schmitz

Author Affiliations

1: Miltenyi Biotec GmbH, Bergisch Gladbach, Germany. AmCell Corporation, Sunnyvale, CA 94089, USA.

Associated clinical trials:

Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients (DECENDO) | NCT04212377

Articles citing this

(truncated to the top 100)

Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 5.37

The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol (2013) 4.75

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med (2010) 4.17

Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med (2009) 4.03

Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 3.95

The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med (2002) 3.91

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med (2010) 3.84

Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol (2012) 3.81

Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity (2012) 3.58

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med (2010) 3.43

Dendritic cell and macrophage heterogeneity in vivo. Immunity (2011) 3.41

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell (2014) 3.40

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med (2001) 3.40

Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest (2008) 3.14

A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med (2001) 3.03

Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev (2010) 2.55

CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J Biol Chem (2008) 2.34

Dendritic-cell-based therapeutic cancer vaccines. Immunity (2013) 2.29

Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J Exp Med (2010) 2.26

Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J Immunol (2005) 2.17

Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest (2005) 2.10

Immunology of psoriasis. Annu Rev Immunol (2014) 2.06

Designing vaccines based on biology of human dendritic cell subsets. Immunity (2010) 2.04

Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol (2012) 1.95

Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.90

Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia. Sci Transl Med (2011) 1.79

Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med (2012) 1.78

Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol (2007) 1.74

The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J Clin Invest (2009) 1.73

Resident and "inflammatory" dendritic cells in human skin. J Invest Dermatol (2008) 1.72

Transcriptional programming of the dendritic cell network. Nat Rev Immunol (2012) 1.70

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev (2008) 1.68

Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells. J Virol (2003) 1.64

Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood (2005) 1.58

Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med (2005) 1.54

Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa. J Virol (2005) 1.54

Human dendritic cell subsets. Immunology (2013) 1.49

BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol (2007) 1.49

Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J Immunol (2007) 1.47

Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax (2001) 1.47

Harnessing human dendritic cell subsets for medicine. Immunol Rev (2010) 1.46

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica (2010) 1.45

Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineages. EMBO J (2011) 1.41

Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J Exp Med (2013) 1.40

Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol (2009) 1.39

The role of type I interferon production by dendritic cells in host defense. Biochimie (2007) 1.33

Human dendritic cell deficiency: the missing ID? Nat Rev Immunol (2011) 1.32

The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria. Infect Immun (2006) 1.28

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut (2005) 1.27

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther (2006) 1.27

Dendritic cells and tumor microenvironment: a dangerous liaison. Immunol Invest (2006) 1.26

Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture. Diabetes (2008) 1.26

Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. J Exp Med (2013) 1.25

Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology (2005) 1.25

CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J Immunol (2009) 1.23

Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β. Immunity (2013) 1.23

Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Immunology (2007) 1.22

The Dectin-2 family of C-type lectins in immunity and homeostasis. Cytokine (2009) 1.20

Differential dysfunction in dendritic cell subsets during chronic HCV infection. Clin Immunol (2007) 1.17

Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells. Virology (2007) 1.17

Dendritic cells in atherosclerotic disease. Clin Immunol (2009) 1.17

Human dendritic cell functional specialization in steady-state and inflammation. Front Immunol (2014) 1.16

The Dectin-2 family of C-type lectin-like receptors: an update. Int Immunol (2013) 1.16

CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens. J Exp Med (2013) 1.16

Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum (2009) 1.15

Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients. PLoS One (2010) 1.15

Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax (2006) 1.14

The plasmacytoid monocyte/interferon producing cells. Virchows Arch (2003) 1.13

CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood (2013) 1.12

Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J Gastroenterol (2006) 1.11

IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa. Blood (2008) 1.10

Targeting human dendritic cell subsets for improved vaccines. Semin Immunol (2011) 1.09

Human dendritic cell subsets for vaccination. J Clin Immunol (2005) 1.09

Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells. PLoS One (2009) 1.09

Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther (2005) 1.08

CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol (2006) 1.08

Characterization of virus-responsive plasmacytoid dendritic cells in the rhesus macaque. Clin Diagn Lab Immunol (2005) 1.08

Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles. Am J Pathol (2008) 1.07

The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma. Br J Cancer (2012) 1.07

Effect of SIVmac infection on plasmacytoid and CD1c+ myeloid dendritic cells in cynomolgus macaques. Immunology (2008) 1.06

Lower levels of plasmacytoid dendritic cells in peripheral blood are associated with a diagnosis of asthma 6 yr after severe respiratory syncytial virus bronchiolitis. Pediatr Allergy Immunol (2008) 1.04

Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Clin Exp Immunol (2009) 1.04

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets. Front Immunol (2014) 1.04

Lung dendritic cells at the innate-adaptive immune interface. J Leukoc Biol (2011) 1.03

Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood (2007) 1.03

Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor. Clin Dev Immunol (2007) 1.02

Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C. Virulence (2012) 1.01

Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity. J Immunol (2012) 1.00

New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation. Ann N Y Acad Sci (2011) 1.00

Immunological functions of the neuropilins and plexins as receptors for semaphorins. Nat Rev Immunol (2013) 1.00

Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. PLoS One (2011) 0.99

Blood Monocytes and Their Subsets: Established Features and Open Questions. Front Immunol (2015) 0.99

Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria. Clin Immunol (2009) 0.99

Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes. Gut (2009) 0.98

An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods (2008) 0.98

Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine. Mol Immunol (2008) 0.98

Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood. Clin Immunol (2008) 0.98

BDCA-1+, BDCA-2+ and BDCA-3+ dendritic cells in early human pregnancy decidua. Clin Exp Immunol (2008) 0.98

Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation. Clin Exp Immunol (2009) 0.98

Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium. Clin Vaccine Immunol (2006) 0.97

Articles by these authors

Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A (2000) 10.88

AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood (1997) 7.84

A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood (1997) 5.04

Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology (1996) 3.49

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med (2001) 3.40

Purification of the human intestinal brush border membrane. Biochim Biophys Acta (1973) 3.38

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem (2000) 3.33

Role of trans-activating proteins in the generation of active chromatin at the PHO5 promoter in S. cerevisiae. EMBO J (1990) 3.29

A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients. J Biomol NMR (1994) 3.16

Enhancement of SIV infection with soluble receptor molecules. Science (1990) 3.15

Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol (2001) 2.71

Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur J Immunol (1994) 2.65

Structural and functional requirements for the chromatin transition at the PHO5 promoter in Saccharomyces cerevisiae upon PHO5 activation. J Mol Biol (1993) 2.57

Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest (1990) 2.46

Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors. Nature (1992) 2.27

Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science (1992) 2.24

The transactivation domain of Pho4 is required for nucleosome disruption at the PHO5 promoter. EMBO J (1994) 2.13

Net costs of dementia by disease stage. Acta Psychiatr Scand (2011) 2.11

Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09

North American Multicenter Study on flow cytometric enumeration of CD34+ hematopoietic stem cells. J Hematother (1996) 2.03

Direct bioautography on thin-layer chromatograms as a method for detecting fungitoxic substances. J Chromatogr (1970) 2.02

A nucleosome precludes binding of the transcription factor Pho4 in vivo to a critical target site in the PHO5 promoter. EMBO J (1994) 2.00

Syndrome of intractable diarrhoea with persistent villous atrophy in early childhood: a clinicopathological survey of 47 cases. J Pediatr Gastroenterol Nutr (1998) 1.97

Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med (1988) 1.95

The yeast NuA4 and Drosophila MSL complexes contain homologous subunits important for transcription regulation. J Biol Chem (2000) 1.92

Free energy change of ATP-hydrolysis: a causal factor of early hypoxic failure of the myocardium? J Mol Cell Cardiol (1982) 1.90

Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol (1989) 1.87

[Morphometric study of the distribution of a specific cytoplasmatic organoid in the rat's endothelial cells]. Z Zellforsch Mikrosk Anat (1966) 1.81

Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest (2001) 1.71

Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res (1997) 1.66

A dihydroxyboryl-substituted methacrylic polymer for the column chromatographic separation of mononucleotides, oligonucleotides, and transfer ribonucleic acid. Biochemistry (1973) 1.62

Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS (1997) 1.58

The effect of alcohol withdrawal on serum concentrations of Lp(a), apolipoproteins A-1 and B, and lipids. Alcohol Clin Exp Res (1992) 1.57

The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmacol Ther (2011) 1.55

Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health (1998) 1.54

F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas. Leuk Lymphoma (2007) 1.54

Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur J Immunol (1999) 1.53

Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52

A silicon-based electrical source of surface plasmon polaritons. Nat Mater (2009) 1.50

The nosologic status of the remitting atypical psychoses. Compr Psychiatry (1989) 1.50

Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50

New zwitterionic detergents improve the analysis of membrane proteins by two-dimensional electrophoresis. Electrophoresis (1998) 1.49

Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc Natl Acad Sci U S A (1995) 1.49

Compliance with tuberculosis treatment in methadone-maintained patients: behavioral interventions. J Subst Abuse Treat (1993) 1.48

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology (1998) 1.48

Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol (2000) 1.48

Detection of Mycobacterium paratuberculosis by polymerase chain reaction in children with Crohn's disease. J Infect Dis (1994) 1.46

LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett (1999) 1.46

Influenza surveillance during winter 1997-1998 in Israel. Isr Med Assoc J (2001) 1.44

Sequential production of IL-2, IFN-gamma and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes. Eur J Immunol (1998) 1.44

Increased HLA-DR expression by enterocytes in children with celiac disease. Gastroenterology (1986) 1.40

Comparison of Prenatal Risk Calculation (PRC) with PIA Fetal Database software in first-trimester screening for fetal aneuploidy. Ultrasound Obstet Gynecol (2009) 1.40

A carbon-13 breath test to characterize glucose absorption and utilization in children. J Pediatr Gastroenterol Nutr (1989) 1.39

[Fatal post-traumatic alcohol delirium--compensation responsibility in private accident insurance?]. Versicherungsmedizin (1997) 1.39

Detection of deep venous thrombi and pulmonary embolus with technetium-99m-DD-3B6/22 anti-fibrin monoclonal antibody Fab' fragment. J Nucl Med (1994) 1.39

Recovery of kidney function following prolonged acute renal failure. Proc Eur Dial Transplant Assoc (1979) 1.38

Immunoglobulin-related amyloidosis presenting as recurrent isolated lymph node involvement. Arch Pathol Lab Med (1991) 1.38

Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation (1985) 1.34

A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet (2001) 1.34

Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology (2000) 1.33

Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med (1992) 1.33

The trans-eliminative breakdown of Na-polygalacturonate by Pseudomonas fluorescens. Antonie Van Leeuwenhoek (1965) 1.33

Plexiform angiomyxoid myofibroblastic tumour: differential diagnosis of gastrointestinal stromal tumour in the stomach. J Clin Pathol (2008) 1.33

Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion. Eur J Immunol (1999) 1.31

Molecular-mechanical studies of the mismatched base analogs of d(CGCGAATTCGCG)2:d(CGTGAATTCGCG)2, d(CGAGAATTCGCG)2, d(CGCGAATTCACG)2, d(CGCGAATTCTCG)2, and d(CGCAGAATTCGCG).d(CGCGAATTCGCG). Biopolymers (1984) 1.30

Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol (1998) 1.29

Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Biochem J (1998) 1.28

Dynamic cortical activity in the human brain reveals motor equivalence. Nature (1998) 1.27

Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology (1986) 1.27

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut (2005) 1.27

Familial microvillous atrophy: a clinicopathological survey of 23 cases. J Pediatr Gastroenterol Nutr (1992) 1.26

Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut (1993) 1.25

CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut (1998) 1.25

Behavioral and emotional problems among children of cocaine- and opiate-dependent parents. J Am Acad Child Adolesc Psychiatry (1999) 1.24

p40(phox) is phosphorylated on threonine 154 and serine 315 during activation of the phagocyte NADPH oxidase. Implication of a protein kinase c-type kinase in the phosphorylation process. J Biol Chem (1998) 1.24

Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids (1990) 1.23

Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med (1999) 1.21

[Hearing disorders in chronic kidney failure]. Monatsschr Ohrenheilkd Laryngorhinol (1972) 1.20

Synthesis of species-specific stress proteins by virulent strains of Listeria monocytogenes. Infect Immun (1990) 1.17

Recombinant type A and B phytochromes from potato. Transient absorption spectroscopy. Biochemistry (1997) 1.16

Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke (2005) 1.16

Monoclonal antibodies specific for cell culture mycoplasmas. In Vitro (1982) 1.16

The use of routine laboratory data to predict in-hospital death in medical admissions. Resuscitation (2005) 1.15

Scatter factor expression and regulation in human glial tumors. Int J Cancer (1996) 1.15

Reconstitution of the thermostable trimeric phage P22 tailspike protein from denatured chains in vitro. J Biol Chem (1989) 1.15

Particulate matter less than 10 microns (PM10) and fine particles less than 2.5 microns (PM2.5): relationships between indoor, outdoor and personal concentrations. Sci Total Environ (1997) 1.15

Ribosomal frameshifting in plants: a novel signal directs the -1 frameshift in the synthesis of the putative viral replicase of potato leafroll luteovirus. EMBO J (1992) 1.15

Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. J Clin Psychopharmacol (1995) 1.14

Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene (1997) 1.14

Connecting cortical and behavioral dynamics: bimanual coordination. Neural Comput (1998) 1.14

Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters. J Immunol Methods (2005) 1.14

Intracellular pathways of copper trafficking in yeast and humans. Adv Exp Med Biol (1999) 1.11

Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg (1994) 1.11

Biological assessment of exposure to antimony and lead in the glass-producing industry. Int Arch Occup Environ Health (1987) 1.10

[Effect of BAY a 1040 on renal function in hypertension]. Arzneimittelforschung (1972) 1.10

Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest (1997) 1.10